Cite
HARVARD Citation
Kirchgesner, J. et al. (2022). Calibrating Real‐World Evidence Studies Against Randomized Trials: Treatment Effectiveness of Infliximab in Crohn's Disease. Clinical pharmacology & therapeutics. 111 (1), pp. 179-186. [Online].